Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of HYR-PB21 local infiltration for post-hemorrhoidectomy analgesia
ChiCTR2400080784Phase 3Recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of HYR-PB21 in postoperative pain (3 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoint: NRS AUC0-72h. Started Feb 2024; status: recruiting.
02
Drugs
HYR-PB21
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400080784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080784.